Literature DB >> 31176296

Susac Syndrome: Clinical characteristics, diagnostic findings and treatment in 19 cases.

S Zengin Karahan1, C Boz2, S Saip3, N Kale4, S Demirkaya5, Y Celik6, S Demir7, A Kurne8, S Erer Ozbek9, M Terzi10.   

Abstract

Susac's Syndrome (SS), which was first described in 1979, is a rare and presumably autoimmune disorder characterized by encephalopathy, hearing loss, and visual disturbance resulting from branch retinal artery occlusion (BRAO). This study reports 19 SS patients' clinical characteristics, MRI features, CSF analysis, treatment strategies and outcomes. At initial presentation, only three of 19 patients demonstrated the complete clinical triad. Clinic presentation varied from isolated hemiparesis to the full triad (encephalopathy, hearing loss and visual disturbances). Corpus callosum (CC) involvement was noted in the MRI of 18 patients (97%) and BRAO was detected in 17 (95%) patients. All patients were treated with intravenous methylprednisolone after the initial assessment. This case series is presented to emphasize the differences in clinical presentation of SS and the importance of MRI and FFA in diagnosis.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Branch retinal artery occlusion; Corpus callosum; Susac Syndrome

Mesh:

Substances:

Year:  2019        PMID: 31176296     DOI: 10.1016/j.msard.2019.05.018

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  3 in total

Review 1.  Scoping review of cochlear implantation in Susac's syndrome.

Authors:  Philip L Pérez; Andrew A McCall; Barry E Hirsch
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2021-01-19

2.  Susac's syndrome as an autoimmune complication of alemtuzumab-associated immune reconstitution.

Authors:  Amir Ahmed; Zi Qi Kok; Alasdair Coles; Daniel J Scoffings; Sarah J Crisp
Journal:  J Neurol       Date:  2021-09-29       Impact factor: 4.849

3.  Susac Syndrome Following COVID-19 Vaccination: A Case Report.

Authors:  Po-Jui Chen; Yi-Sheng Chang; Chen-Chee Lim; Yu-Kuei Lee
Journal:  Vaccines (Basel)       Date:  2022-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.